XML 44 R34.htm IDEA: XBRL DOCUMENT v3.19.1
INVESTMENTS - RELATED PARTIES (Tables)
3 Months Ended
Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Schedule of investments

Investments in AVLP and Alzamend at March 31, 2019 and December 31, 2018, are comprised of the following:

 

    March 31,     December 31,  
    2019     2018  
Investment in convertible promissory note of AVLP   $ 7,732,660     $ 6,943,997  
Accrued interest in convertible promissory note of AVLP     1,214,509       1,004,317  
Total investment in convertible promissory note of AVLP – Gross     8,947,169       7,948,314  
Less: original issue discount     (1,974,791 )     (2,336,693 )
Total investment in convertible promissory note of AVLP   $ 6,972,378     $ 5,611,621  
                 
Investment in derivative instruments of AVLP     1,751,868       2,230,641  
Investment in common stock of AVLP     633,214       812,858  
Investment in common stock of Alzamend     176,250       —  
Investment in derivative instruments and common stock of AVLP and Alzamend   $ 2,561,332     $ 3,043,499  
                 
Total investment in AVLP and Alzamend – Net   $ 9,533,710     $ 8,655,120  
Schedule of summarizes the changes in our investments

The following table summarizes the changes in our investments in AVLP and Alzamend during the three months ended March 31, 2019:

 

    Investment in              
    warrants and     Investment in     Total  
    common stock     convertible     investment  
    of AVLP and     promissory     in AVLP and  
    Alzamend     note of AVLP     Alzamend – Net  
Balance at January 1, 2019   $ 3,043,499     $ 5,611,621     $ 8,655,120  
Investment in convertible promissory notes of AVLP     —       530,756       530,756  
Investment in common stock of AVLP and Alzamend     135,790       —       135,790  
Fair value of derivative instruments issued by AVLP     257,907       —       257,907  
Unrealized loss in derivative instruments of AVLP     (736,680 )     —       (736,680 )
Unrealized loss in common stock of AVLP and Alzamend     (139,184 )     —       (139,184 )
Accretion of discount     —       619,809       619,809  
Accrued Interest     —       210,192       210,192  
Balance at March 31, 2019   $ 2,561,332     $ 6,972,378     $ 9,533,710